![]() |
![]() |
The Harvard Department of Ophthalmology is one of the leading and largest academic departments of Ophthalmology in the nation and a major recipient of NIH funding. With 121 full-time clinical and basic science faculty, it continues to make significant contributions to ophthalmic and vision research in virtually all basic, applied, and clinical subspecialty areas.
The Harvard-Vision Clinical Scientist Development Program proposes to offer a customized and structured learning, research, and development environment to a select group of qualified clinically-trained candidates who have recently completed (or about to complete) their training, but who desire further mentored learning experience so as to become independent leading clinical scientists in their respective fields.
Trainees in this program will (i) complete a core curriculum that will include the Harvard Program in Clinical Effectiveness (PCE) – a summer-long immersion program in biostatistics, epidemiology, study design, and outcomes measurement. Additional required curricular activities will include the Harvard Medical School course, Neurobiology 300 “Biologic Bases of Ophthalmic Disease,” a multidisciplinary survey course focusing on the biological mechanisms (genetics, immunology, neuroscience, vascular biology) of eye disease.
Candidates will also (ii) perform research in a closely mentored program under the guidance of lead mentors who are leaders in their respective fields with the express objective of allowing them to develop into independent investigators. Trainees in this program will additionally have the option of seeking an advanced degree (MS, MPH, PhD, ScD) at Harvard.
The extraordinary growth and specialization that has occurred over the past several decades in the sciences has made it increasingly difficult to link the increasing divide between clinical and basic science components of ophthalmic and vision sciences. The less-than-optimal degree of cross-talk between scientists engaged in studying fundamental biological processes and clinicians providing care to patients has had multiple deleterious effects. Continued external factors are expected to impact this trend negatively for the foreseeable future.
Traditional approaches, based purely on didactic curricula, to “teach” basic sciences to highly-trained clinicians are only variably effective as they offer limited opportunity to these clinicians for hands-on experience in designing and conducting studies. Additionally, many clinicians engaged in pure clinical (vs. bench-based) research have had very limited formal training in methodological aspects of clinical study design and execution.
To address these needs the Harvard-Vision Clinical Scientist Development Program is seeking to recruit and train clinician-scientists as detailed below.
We are seeking subspecialty/fellowship-trained board-certified/eligible ophthalmologists (or optometrists) to commit, at the level of Junior Faculty with 80% of their time dedicated to structured research and the development program under mentorship of one of our senior faculty. The duration of commitment will be 3-5 years based on the interests of the candidate and the nature of the mentored training program.
Two competitive positions are available throughout the Harvard Ophthalmology system for July 1 of each academic year.
This program is funded by the National Institutes of Health. For more information about the Harvard-Vision Clinical Scientist Development Program, please contact Cori O’Brien at (617)-573-3311 or cori_o’brien@meei.harvard.edu.
Applications for the 2008 academic year can be obtained as described above or by downloading a pdf version here. Application deadline for July 1, 2008 candidates is October 31, 2007.
Below, are tables listing the ophthalmic subspecialty areas, and academic disciplines and related faculty, offered through the Harvard-Vision Clinical Scientist Development Program.
BWH - Brigham & Women's Hospital
CH - Boston Children's Hospital
HMS - Harvard Medical School
HSPH - Harvard School of Public Health
HU - Harvard University
JDC - Joslin Diabetes Center
MEEI - Massachusetts Eye and Ear Infirmary
MGH - Massachusetts General Hospital
SERI - Schepens Eye Research Institute
Ocular Area of Concentration |
Mentors & Faculty (may be listed in >1 area of expertise) |
Institution |
| Tear Film & Ocular Surface | Darlene Dartt, PhD Ilene Gipson, PhD David Sullivan, PhD James Zieske, PhD |
SERI SERI SERI SERI |
| Cornea & Anterior Segment | Kathryn Colby, MD, PhD M. Reza Dana, MD, MPH Darlene Dartt, PhD Ilene Gipson, PhD |
MEEI and SERI MEEI and SERI MEEI and SERI SERI SERI MEEI |
| Glaucoma | Cynthia Grosskreutz, MD, PhD Janey L. Wiggs, MD, PhD |
MEEI MEEI |
| Uveitis & Ocular Inflammation | M. Reza Dana, MD, MPH | MEEI and SERI MEEI |
| Ocular Microbiology | Michael Gilmore, PhD Kathryn Colby, MD, PhD |
SERI MEEI and SERI |
| Pediatric Ophthalmology | David G. Hunter, MD | Children's |
| Nutrition & Disease | Susan Hankinson, ScD, MPH Debra Schaumberg, ScD, MPH |
HMS HMS Epidemiology MEEI |
| Low Vision | Eli Peli, OD David G. Hunter, MD (pediatric) |
SERI Children's |
| Ocular Oncology | Evangelos Gragoudas, MD |
MEEI MEEI |
| Retina | ||
| Physiology & Development | John Dowling, PhD Tiansen Li, PhD Richard Masland, PhD |
MEEI HU, Biological Labs MEEI MGH |
| Macular Degeneration | Evangelos Gragoudas, MD Joan Miller, MD |
MEEI MEEI |
| Proliferative Vitreoretinopathy | Lloyd Paul Aiello, MD, PhD Robert D'Amato, MD, PhD Patrician D'Amore, PhD Andrius Kazlauskas, PhD Mara Lorenzi, MD Joan W. Miller, MD Lois Smith, MD, PhD |
JDC CH & MEEI SERI SERI SERI & MGH MEEI CH |
| Inherited Retinopathies | Eliot Berson, MD Tiansen Li, PhD |
MEEI MEEI MEEI |
Expert Discipline |
Mentors & Faculty (may be listed in >1 area of expertise) |
Institution |
| Biostatistics & Epidemiology | Robert Glynn, ScD Susan Hankinson, ScD, MPH Debra Schaumberg, ScD Meir Stampfer, MD, DrPH |
BWH HMS HMS Epidemiology MEEI HSPH |
| Clinical Trials | Francis Cook, ScD, MS Robert Glynn, ScD Evangelos Gragoudas, MD Joan Miller, MD | HMS, Clin. Effect Prog. BWH MEEI MEEI MEEI |
| Immunology & Microbiology | M. Reza Dana, MD, MPH Michael Gilmore, PhD |
MEEI & SERI MEEI SERI |
| Physiology | Darlene Dartt, PhD Ilene Gipson, PhD David G. Hunter, MD David Sullivan, PhD James Zieske, PhD |
SERI SERI CH SERI SERI |
| Development | John Dowling, PhD | HMS, Biological Labs |
| Genetics | Eliot Berson, MD Janey L. Wiggs, MD, PhD |
MEEI MEEI MEEI |
| Vascular & Endothelial Biology | Lloyd Paul Aiello, MD, PhD Patrician D'Amore, PhD Mara Lorenzi, MD Lois Smith, MD, PhD |
JDC SERI SERI & MGH CH |
| Matrix Remodeling & Angiogenesis |
Lloyd Paul Aiello, MD, PhD Patrician D'Amore, PhD M. Reza Dana, MD, MPH Joan Miller, MD |
JDC MEEI & SERI SERI MEEI & SERI MEEI |
| Cell Biology | Ilene Gipson, PhD Cynthia Grosskreutz, MD, PhD Andrius Kazlauskas, PhD James Zieske, PhD |
SERI MEEI SERI SERI |
| Neurobiology | John Dowling, PhD Tiansen Li, PhD Richard Masland, PhD |
MEEI HMS, Biological Labs MEEI MGH |
| Optics | Eli Peli, ODMEEI & SERI SERI |
|
|
|